Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-61,589
Closed -$4.68M 690
2022
Q2
$4.68M Buy
61,589
+28,926
+89% +$2.2M 0.02% 265
2022
Q1
$2.59M Sell
32,663
-3,310
-9% -$241K 0.01% 358
2021
Q4
$2.64M Buy
+35,973
New +$2.43M 0.01% 293

Other funds holding INCY

Brookfield Corp's INCY Position: Q3 2022 in Review

Brookfield Corp sold out of Incyte (INCY) in Q3 2022, closing a stake of 61,589 shares — an estimated $4.68M sold.

Brookfield Corp first reported a position in INCY in Q4 2021 and held it in 3 quarters. The position peaked at $4.68M in Q2 2022. 537 funds tracked by Wall St. Rank hold INCY as of Q3 2022.

  • Brookfield Corp reported no remaining Incyte position as of Q3 2022 after selling out during the quarter.
  • Brookfield Corp sold 61,589 Incyte shares in Q3 2022, an estimated $4.68M.
  • Brookfield Corp first reported a position in Incyte in Q4 2021 and held it in 3 quarters.
  • Brookfield Corp's Incyte position peaked at $4.68M in Q2 2022.
  • 537 funds tracked by Wall St. Rank held Incyte as of Q3 2022.

Based on Brookfield Corp's 13F filing for Q3 2022, filed 14 Nov 2022.